Most COVID-19 Patients Benefit at Long-Term Acute Care Hospitals

WEDNESDAY, April 6, 2022 (HealthDay News) -- For patients with COVID-19, care at a long-term acute care hospital (LTACH) seems beneficial, according to a study published in the January to March volume of JMIR Rehabilitation and Assistive Technologies.
Pete Grevelding, P.T., from Gaylord Specialty Healthcare in Wallingford, Connecticut, and colleagues describe the characteristics, clinical management, and patient outcomes occurring during and after acute COVID-19 in an LTACH. Electronic medical records of patients treated for COVID-19-related impairments from March 19, 2020, through Aug. 14, 2020 (118 patients) and a reference population of medically complex patients discharged Dec. 1, 2019, to Feb. 29, 2020, were reviewed.
The researchers found that the mean length of stay was similar for the COVID-19 cohort and the reference cohort. In the COVID-19 cohort, but not the reference cohort, there was a positive correlation observed between patient age and length of stay. From admission to discharge, the ambulation assistance scores improved in both the COVID-19 and reference cohorts; at discharge, the mean assistance score was greater in the COVID-19 versus the reference cohort (4.9 versus 4.1). Similarly, the mean change in gait distance was greater in the COVID-19 versus the reference cohort (221.1 versus 146.4 feet). Ninety-four percent of the 16 mechanically ventilated patients at admission were weaned before discharge; 75 percent of the 75 patients admitted with a restricted diet were discharged on a regular diet.
"These observations indicate the potential benefits of individualized, focused, and holistic rehabilitation in a population severely affected by COVID-19," the authors write.
Related Posts
Merck pedirá a la FDA la aprobación de emergencia de su nueva pastilla antiviral contra la COVID
VIERNES, 1 de octubre de 2021 (HealthDay News) -- La gigante farmacéutica Merck...
Opdivo Could Boost Outcomes for People Battling Hodgkin Lymphoma
TUESDAY, July 6, 2023 (HealthDay News) -- The widely used immunotherapy drug...
Las prohibiciones locales de los productos de tabaco con sabores reducen el uso en California
LUNES, 29 de mayo de 2023 (HealthDay News) -- Prohibir los productos de tabaco...
Air Pollution Exposure May Up Risk for Autoimmune Disease
FRIDAY, March 18, 2022 (HealthDay News) -- Long-term exposure to air pollution...
